These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical pharmacologic observations on timolol. I. Disposition and effect in relation to plasma level in normal individuals. Ishizaki T; Tawara K; Oyama Y; Nakaya H J Clin Pharmacol; 1978; 18(11-12):511-8. PubMed ID: 721948 [TBL] [Abstract][Full Text] [Related]
6. Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man. Wellstein A; Palm D; Pitschner HF; Belz GG Eur J Clin Pharmacol; 1985; 29(2):131-47. PubMed ID: 3000793 [TBL] [Abstract][Full Text] [Related]
7. Plasma timolol levels and systolic time intervals. Singh BN; Williams FM; Whitlock RM; Collett J; Chew C Clin Pharmacol Ther; 1980 Aug; 28(2):159-66. PubMed ID: 7398183 [TBL] [Abstract][Full Text] [Related]
8. Presystemic and systemic glucuronidation of propranolol. Walle T; Fagan TC; Conradi EC; Walle UK; Gaffney TE Clin Pharmacol Ther; 1979 Aug; 26(2):167-72. PubMed ID: 455886 [TBL] [Abstract][Full Text] [Related]
9. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects. Ferro A; Hall JA; Dickerson JE; Brown MJ Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585 [TBL] [Abstract][Full Text] [Related]
11. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops. Korte JM; Kaila T; Saari KM Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):430-5. PubMed ID: 12107508 [TBL] [Abstract][Full Text] [Related]
12. Effects of oral befunolol on heart rate and systolic blood pressure during submaximal exercise in man. Miki N; Furusho Y; Itaya K; Midorikawa K; Kumagai E; Terasawa M; Ihara S; Matoba T; Toshima H Jpn Circ J; 1980 Oct; 44(10):783-93. PubMed ID: 6107392 [TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic receptors in the elderly are not less sensitive to timolol. Klein C; Gerber JG; Gal J; Nies AS Clin Pharmacol Ther; 1986 Aug; 40(2):161-4. PubMed ID: 3015473 [TBL] [Abstract][Full Text] [Related]
14. Estimation of the systemic bioavailability of timolol in man. El-Rashidy R Biopharm Drug Dispos; 1981; 2(2):197-202. PubMed ID: 7248483 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction. Edeki TI; He H; Wood AJ JAMA; 1995 Nov 22-29; 274(20):1611-3. PubMed ID: 7474246 [TBL] [Abstract][Full Text] [Related]
16. Comparisons of the interaction of propranolol and timolol with model and biological membrane systems. Herbette L; Katz AM; Sturtevant JM Mol Pharmacol; 1983 Sep; 24(2):259-69. PubMed ID: 6888369 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Brown HC; Carruthers SG; Johnston GD; Kelly JG; McAinsh J; McDevitt DG; Shanks RG Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125 [TBL] [Abstract][Full Text] [Related]
18. Duration of cardiac effects of timolol and propranolol. Achong MR; Piafsky KM; Ogilvie RI Clin Pharmacol Ther; 1976 Feb; 19(2):148-52. PubMed ID: 4254 [TBL] [Abstract][Full Text] [Related]
19. Plasma timolol levels after oral and intravenous administration. Else OF; Sorenson H; Edwards IR Eur J Clin Pharmacol; 1978 Dec; 14(6):431-4. PubMed ID: 738350 [TBL] [Abstract][Full Text] [Related]
20. The effect of ageing on the hepatic clearance of propranolol. Castleden CM; George CF Br J Clin Pharmacol; 1979 Jan; 7(1):49-54. PubMed ID: 760742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]